Terms: = Leukemia AND COL2A1, SEDC, MGC131516, COL11A3, AOM, ANFH, ENSG00000139219, 1280 AND Prognosis
2 results:
1. SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia.
Wu DL; Wang Y; Zhang TJ; Chu MQ; Xu ZJ; Yuan Q; Ma JC; Lin J; Qian J; Zhou JD
Eur J Med Res; 2022 Nov; 27(1):259. PubMed ID: 36411451
[TBL] [Abstract] [Full Text] [Related]
2. Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study.
Kornblau SM; Banker DE; Stirewalt D; Shen D; Lemker E; Verstovsek S; Estrov Z; Faderl S; Cortes J; Beran M; Jackson CE; Chen W; Estey E; Appelbaum FR
Blood; 2007 Apr; 109(7):2999-3006. PubMed ID: 17158228
[TBL] [Abstract] [Full Text] [Related]
